Jing Li

Yunyun Liu, Hui Li, Zhongqiu Lin, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Feasibility and safety of neoadjuvant laparoscopic hyperthermic intraperitoneal chemotherapy in patients with advanced stage ovarian cancer: a single-center experience

Zhongqiu Lin, Wu-yun Wang, Miao-Fang Wu, 2019, Cancer management and research.

Comprehensive lymphadenectomy and survival prediction in uterine serous cancer patients after surgery: A population-based analysis.

Yunyun Liu, Hui Li, Zhongqiu Lin, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Efficacy of neoadjuvant hyperthermic intraperitoneal chemotherapy in advanced high-grade serous ovarian cancer (the NHIPEC trial): study protocol for a randomised controlled trial

Zhongqiu Lin, Jibin Li, Chang Liu, 2021, BMJ Open.

The added value of CA125 normalization before interval debulking surgery to the chemotherapy response score for the prognostication of ovarian cancer patients receiving neoadjuvant chemotherapy for advanced disease

Chang Liu, Li-juan Wang, Miao-Fang Wu, 2020, Journal of Cancer.

Comparison of two types of the triple incision technique in the treatment of patients with locally advanced vulvar cancer

Zhongqiu Lin, Chang Liu, Miao-Fang Wu, 2020, International journal of medical sciences.

A modified triple incision technique for women with locally advanced vulvar cancer: a description of the technique and outcomes.

Zhongqiu Lin, Li-juan Wang, Jing Li, 2012, European journal of obstetrics, gynecology, and reproductive biology.

Neoadjuvant chemotherapy with paclitaxel plus platinum for invasive cervical cancer in pregnancy: two case report and literature review

Zhongqiu Lin, Li-juan Wang, Jing Li, 2011, Archives of Gynecology and Obstetrics.

The association between XRCC1 genetic polymorphisms and the risk of endometrial carcinoma in Chinese.

Zhongqiu Lin, Li-juan Wang, Jing Li, 2015, Gene.

CircCASC15-miR-100-mTOR may influence the cervical cancer radioresistance

Chunxian Huang, Jing Li, Ruixin Li, 2021, Cancer cell international.

Can radical parametrectomy be omitted in occult cervical cancer after extrafascial hysterectomy?

Yunyun Liu, Zhongqiu Lin, Chang Liu, 2015, Chinese journal of cancer.

Effects of neoadjuvant hyperthermic intraperitoneal chemotherapy on chemotherapy response score and recurrence in high‐grade serous ovarian cancer patients with advanced disease: A multicentre retrospective cohort study

Hui Li, Zhongqiu Lin, Wei Liang, 2022, BJOG : an international journal of obstetrics and gynaecology.

Identification of Ovarian Cancer Patients Most Likely to Achieve Chemotherapy Response Score 3 Following Neoadjuvant Chemotherapy: Development of a Predictive Nomogram

Hui Li, Chang Liu, Miao-Fang Wu, 2020, Frontiers in Oncology.

Aberrant microRNA expression in human cervical carcinomas

Zhongqiu Lin, Jing Li, Hui Zhou, 2012, Medical Oncology.

Association analysis between 8‐oxoguanine DNA glycosylase genetic variants and endometrial cancer susceptibility in Chinese Han population

Zhongqiu Lin, Li-juan Wang, Miao-Fang Wu, 2015, The Journal of pharmacy and pharmacology.

Genomic and expressional dynamics of ovarian cancer cell lines in PARPi treatment revealed mechanisms of acquired resistance.

Chunxian Huang, Yunyun Liu, Zhongqiu Lin, 2022, Gynecologic oncology.

Impact of Hyperglycemia on Outcomes among Patients Receiving Neoadjuvant Chemotherapy for Bulky Early Stage Cervical Cancer

Zhongqiu Lin, Li-juan Wang, Miao-Fang Wu, 2016, PloS one.

Long non‑coding RNA urothelial cancer associated 1 regulates radioresistance via the hexokinase 2/glycolytic pathway in cervical cancer.

Chunxian Huang, Zhongqiu Lin, Jing Li, 2018, International journal of molecular medicine.

The added value of fasting blood glucose to serum squamous cell carcinoma antigen for predicting oncological outcomes in cervical cancer patients receiving neoadjuvant chemotherapy followed by radical hysterectomy

Chang Liu, Miao-Fang Wu, Jing Li, 2019, Cancer medicine.

Pretreatment glycemic control status is an independent prognostic factor for cervical cancer patients receiving neoadjuvant chemotherapy for locally advanced disease

Rong Chen, Zhongqiu Lin, Jing Li, 2017, BMC Cancer.

Pretreatment serum lactate dehydrogenase is an independent prognostic factor for patients receiving neoadjuvant chemotherapy for locally advanced cervical cancer

Zhongqiu Lin, Li-juan Wang, Miao-Fang Wu, 2016, Cancer medicine.

Serum miR-638 Combined with Squamous Cell Carcinoma-Related Antigen as Potential Screening Biomarkers for Cervical Squamous Cell Carcinoma.

Liping Feng, C. Jing, Jing Li, 2020, Genetic testing and molecular biomarkers.

A Dose-Finding Trial for Hyperthermic Intraperitoneal Cisplatin in Gynecological Cancer Patients Receiving Hyperthermic Intraperitoneal Chemotherapy

Hui Li, Zhongqiu Lin, Chang Liu, 2021, Frontiers in Oncology.

ALDH-1-positive cells exhibited a radioresistant phenotype that was enhanced with hypoxia in cervical cancer

Chunxian Huang, Zhongqiu Lin, Yao Yao, 2020, BMC cancer.

Impact of Poor Preoperative Glycemic Control on Outcomes among Patients with Cervical Cancer Undergoing a Radical Hysterectomy

Li-juan Wang, Miao-Fang Wu, Jing Li, 2019, Oncology Research and Treatment.

Pretreatment glycemic control status is an independent prognostic factor for cervical cancer patients receiving neoadjuvant chemotherapy for locally advanced disease

Rong Chen, Li-juan Wang, Jing Li, 2017, BMC Cancer.

Co-Overexpression of GRK5/ACTC1 Correlates With the Clinical Parameters and Poor Prognosis of Epithelial Ovarian Cancer

Chunlin Chen, Jing Li, Yingxia Ning, 2022, Frontiers in Molecular Biosciences.

Safety of fertility-sparing surgery in young women with stage I endometrioid epithelial and mucinous ovarian cancer: A population-based analysis.

Zhongqiu Lin, Jing Li, Aoshuang Cheng, 2023, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.